Drew Struzan, best known for his iconic work on movie posters for some of the biggest Hollywood blockbusters, is battling Alzheimer’s and “fighting for his life.” His wife Dylan shared the news on ...
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition The Global Alzheimer's Platform Foundation®  (GAP) in collaboration with the  Scottish Funding Council ...
Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after administration of GT-02287, suggest that GT-02287 may have the potential to slow ...
We’re sorry to report that legendary poster artist Drew Struzan, now 78, can no longer paint or even sign his art and is, in ...
The poster for the much-anticipated movie I Know What You Did Last Summer has recently been launched, and it's drop-dead ...
Former glamour model Katie Price, who previously purchased three reborn dolls, shared a picture of a lifelike doll on her ...
Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the ...
Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced it will present new clinical data from its OVERTURE ...
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PDTM 2025 <li /> A ...
Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025 ...
Eisai Inc. announced today that the company will present the latest findings from its robust neurology portfolio, including data on real-world experience and continued maintenance dosing with our dual ...
Title: Methodological approach of a multi-method study to allow the development and implementation of a clinical pharmaceutical competency framework for hospital pharmacists in Austria (Jan 2024) ...